{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:18:54Z","timestamp":1785442734802,"version":"3.56.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/rlu.0b013e31829f57fa","type":"journal-article","created":{"date-parts":[[2013,7,13]],"date-time":"2013-07-13T12:32:52Z","timestamp":1373718772000},"page":"715-720","source":"Crossref","is-referenced-by-count":35,"title":["Prognostic Predictive Value of Total Lesion Glycolysis From 18F-FDG PET\/CT in Post-Surgical Patients With Epithelial Ovarian Cancer"],"prefix":"10.1097","volume":"38","author":[{"given":"Shanshan","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12149-010-0449-8","article-title":"Present and future of FDG-PETCT in ovarian cancer.","volume":"25","author":"Kitajima","year":"2011","journal-title":"Ann Nucl Med"},{"key":"R2-8-20210204","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010.","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"R3-8-20210204","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/RLU.0b013e318219b523","article-title":"Noninvasive and invasive staging of ovarian cancer: review of the literature.","volume":"36","author":"Fuccio","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"Suppl 1","key":"R4-8-20210204","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.2967\/jnumed.108.057257","article-title":"The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.","volume":"50","author":"Schwarz","year":"2009","journal-title":"J Nucl Med"},{"key":"R5-8-20210204","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/jnci\/djp500","article-title":"Predictive value of symptoms for early detection of ovarian cancer.","volume":"102","author":"Rossing","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R6-8-20210204","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cncr.22371","article-title":"Development of an ovarian cancer symptom index: possibilities for earlier detection.","volume":"109","author":"Goff","year":"2007","journal-title":"Cancer"},{"key":"R7-8-20210204","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1148\/rg.312105713","article-title":"Role of FDG PETCT in staging of recurrent ovarian cancer.","volume":"31","author":"Son","year":"2011","journal-title":"Radiographics"},{"key":"R8-8-20210204","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejrad.2009.12.035","article-title":"Present and future of PET and PETCT in gynaecologic malignancies.","volume":"78","author":"Musto","year":"2011","journal-title":"Eur J Radiol"},{"key":"R9-8-20210204","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","article-title":"Diagnostic accuracy of 18F-FDG PETCT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.","volume":"28","author":"Castellucci","year":"2007","journal-title":"Nucl Med Commun"},{"key":"R10-8-20210204","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","article-title":"CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis.","volume":"71","author":"Gu","year":"2009","journal-title":"Eur J Radiol"},{"key":"R11-8-20210204","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/CBM-2011-0219","article-title":"FDG-PETCT as a molecular biomarker in ovarian cancer.","volume":"8","author":"Nowosinska","year":"2010","journal-title":"Cancer Biomark"},{"key":"R12-8-20210204","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","article-title":"Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomographycomputer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis.","volume":"81","author":"Yuan","year":"2012","journal-title":"Eur J Radiol"},{"key":"R13-8-20210204","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00261-007-9218-0","article-title":"PET-CT vs. CT alone in ovarian cancer recurrence.","volume":"33","author":"Sebastian","year":"2008","journal-title":"Abdom Imaging"},{"key":"R14-8-20210204","first-page":"54","article-title":"FDG PETCT in ovarian cancer: what about treatment response and prognosis Clin Nucl Med.","volume":"37","author":"Grassetto","year":"2012","journal-title":""},{"key":"R15-8-20210204","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00259-009-1085-1","article-title":"SUV and segmentation: pressing challenges in tumour assessment and treatment.","volume":"36","author":"Lucignani","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-8-20210204","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.10.060","article-title":"Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.","volume":"74","author":"La","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-8-20210204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1245\/s10434-009-0719-7","article-title":"Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.","volume":"17","author":"Hyun","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R18-8-20210204","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijrobp.2007.04.036","article-title":"Metabolic tumor burden predicts for disease progression and death in lung cancer.","volume":"69","author":"Lee","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-8-20210204","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1258\/ar.2011.100462","article-title":"Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.","volume":"52","author":"Yan","year":"2011","journal-title":"Acta Radiol"},{"key":"R20-8-20210204","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2010.11.002","article-title":"Prognostic value of metabolic tumor volume measured by FDG-PETCT in patients with cervical cancer.","volume":"120","author":"Chung","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R21-8-20210204","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1158\/1078-0432.CCR-08-3290","article-title":"Metabolic tumor volume of 18F-fluorodeoxyglucose positron emission tomographycomputed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer.","volume":"15","author":"Chung","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R22-8-20210204","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00432-009-0729-7","article-title":"Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.","volume":"136","author":"Xie","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"R23-8-20210204","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ygyno.2012.03.021","article-title":"Metabolic tumor volume by 18F-FDG PETCT is prognostic for stage IVB endometrial carcinoma.","volume":"125","author":"Liu","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R24-8-20210204","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1245\/s10434-011-2153-x","article-title":"Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.","volume":"19","author":"Chung","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R25-8-20210204","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.radonc.2008.06.014","article-title":"Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation.","volume":"89","author":"Roedl","year":"2008","journal-title":"Radiother Oncol"},{"key":"R26-8-20210204","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00259-013-2357-3","article-title":"Fifteen different (18)F-FDG PETCT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.","volume":"40","author":"Maffione","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R27-8-20210204","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2009.07.003","article-title":"GTV spatial conformity between different delineation methods by 18FDG PETCT and pathology in esophageal cancer.","volume":"93","author":"Yu","year":"2009","journal-title":"Radiother Oncol"},{"key":"R28-8-20210204","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00259-006-0260-x","article-title":"Role of 18FFDG PETCT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.","volume":"34","author":"Chung","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R29-8-20210204","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ejso.2005.02.029","article-title":"(18)F-FDG PETCT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.","volume":"31","author":"Nanni","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"R30-8-20210204","first-page":"53","article-title":"The pretreatment of maximum standardized uptake values (SUVmax) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian cancer.","volume":"66","author":"Nakamura","year":"2012","journal-title":"Acta Med Okayama"},{"key":"R31-8-20210204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ssu.2980100107","article-title":"FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.","volume":"10","author":"Kosary","year":"1994","journal-title":"Semin Surg Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e31829f57fa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:31:21Z","timestamp":1621884681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201309000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e31829f57fa","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}